IntrinsicIntrinsic
← Scroll for more →

Financial Statements — DAWN

Balance Sheet

(in millions USD)
MetricQ4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Cash & Equivalents197.0843.2835.6233.36124.97422.77239.62270.39230.78241.18189.2149.2785.26120.86388.88262.73284.31297.16310.00
Short-term Investments244.04408.30417.48439.66406.75135.62122.2547.55135.56164.36253.67268.91257.01253.48----------
Accounts Receivable26.7416.7019.6718.0513.888.709.14------------------------
Inventory6.337.066.543.573.322.740.15------------------------
Total Current Assets485.10489.97494.43508.65562.33581.00383.16326.03375.27413.29449.78--347.87------289.37----
Property, Plant & Equipment2.142.232.322.512.290.900.200.190.210.210.180.070.020.040.070.070.060.060.07
Intangible Assets18.0218.8219.6120.4115.63----------------------------
Total Non-current Assets*22.7323.8124.6125.7120.4619.8117.280.610.770.890.97--1.19------0.45----
Total Assets507.83513.78519.04534.36582.79600.81400.44326.65376.05414.18450.76323.56349.06381.86404.05267.78289.82303.78316.54
Accounts Payable54.6248.2144.1343.6468.6335.1987.0724.7626.5220.6519.5217.770.2613.8411.937.301.745.164.11
Total Current Liabilities60.5256.4751.2247.8873.4539.7493.7129.8429.5124.4824.5122.8516.6118.2712.808.188.666.054.66
Total Non-current Liabilities*6.146.456.986.976.595.600.000.000.000.080.190.300.410.510.620.000.020.070.11
Total Liabilities66.6762.9158.2054.8480.0445.3493.7129.8429.5124.5524.7023.1517.0218.7913.428.188.676.114.77
Retained Earnings(661.40)(640.12)(620.40)(590.08)(554.08)(488.37)(525.40)(521.00)(458.58)(404.07)(357.92)(312.06)(269.67)(229.56)(191.76)(155.23)(127.49)(105.55)(86.31)
Total Stockholder Equity441.16450.87460.83479.51502.75555.46306.73296.81346.54389.63426.05300.42332.04363.08390.63259.60281.15297.67311.76
← Scroll for more columns →

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)
MetricQ4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Total Revenue0.050.040.030.030.030.09--------------------------
Research & Development0.040.030.040.040.060.030.090.040.040.030.030.030.030.020.020.020.010.010.01
Selling, General & Admin0.030.030.030.030.030.030.030.030.020.020.020.020.020.020.010.010.010.010.01
Total Operating Expenses0.080.060.070.070.090.060.120.070.060.050.050.050.040.040.040.030.020.020.02
Operating Income(0.03)(0.02)(0.03)(0.04)(0.07)0.03(0.11)(0.07)(0.06)(0.05)(0.05)(0.05)(0.04)(0.04)(0.04)(0.03)(0.02)(0.02)(0.02)
Interest Expense----------------------------------0.000.00
Pretax Income*(107.24)(0.02)(0.03)(0.04)(0.06)0.04-0.00------------------------
Tax Provision-0.000.000.000.000.01-0.000.00------------------------
Net Income(107.24)(0.02)(0.03)(0.04)(0.07)0.04-0.00(0.06)(0.05)(0.05)(0.05)(0.04)(0.04)(0.04)(0.04)(0.03)(0.02)(0.02)(0.02)
Basic EPS(0.21)(0.19)(0.29)(0.35)(0.63)0.38(0.05)(0.72)(0.63)(0.54)(0.61)(0.59)(0.56)(0.53)(0.60)--------
Diluted EPS(0.21)(0.19)(0.29)(0.35)(0.63)0.38(0.05)(0.72)(0.63)(0.54)(0.61)(0.59)(0.56)(0.53)(0.60)--------
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(14.15)(5.80)(24.81)(59.00)(30.01)50.75(49.13)(49.73)(41.37)(37.06)(42.43)(25.98)(35.31)(23.21)(29.79)(21.56)(13.17)(12.22)(23.15)
Capital Expenditures0.000.000.000.321.420.720.030.000.010.040.150.030.000.000.010.02-0.000.000.09
Free Cash Flow*(14.15)(5.80)(24.81)(59.31)(31.43)50.03(49.15)(49.73)(41.38)(37.10)(42.58)(26.01)(35.31)(23.22)(29.79)(21.58)(13.17)(12.22)(23.24)
Investing Cash Flow167.4813.4626.32(32.61)(269.64)(67.70)17.0689.2930.3888.9220.27(11.19)(2.21)(246.85)(6.00)(0.01)0.000.00(8.00)
Financing Cash Flow0.470.000.750.001.85200.101.300.050.600.12162.101.181.922.05161.93128.890.32(0.61)297.42
← Scroll for more columns →

* Derived from reported values